PEAK6
LLY icon

PEAK6’s Eli Lilly LLY Stock Holding History

PEAK6’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$705 Sell
1
-1
-50% -$1.02K ﹤0.01% 2612
2026
Q1 		$2.07K Sell
2
-1
-33% -$1.01K ﹤0.01% 2570
2025
Q4 		$3.21K Sell
3
-1
-25% -$956 ﹤0.01% 2689
2025
Q3 		$2.92K Buy
4
+1
+33% +$744 ﹤0.01% 2786
2025
Q2 		$1.95K Sell
3
-18,954
-100% -$14.7M ﹤0.01% 2822
2025
Q1 		$15.7M Buy
18,957
+12,264
+183% +$10.2M 0.04% 421
2024
Q4 		$5.17M Buy
+6,693
New +$5.54M 0.01% 888

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PEAK6's LLY Position: Q2 2026 in Review

PEAK6 reduced its Eli Lilly (LLY) stake by 50% in Q2 2026, selling an estimated $1.02K and leaving 1 share worth $705. The position accounts for ﹤0.01% of the portfolio, ranked #2612.

PEAK6 first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $15.7M in Q1 2025. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PEAK6 held 1 share of Eli Lilly worth $705 as of Q2 2026.
  • PEAK6 sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2612 holding.
  • PEAK6 first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • PEAK6's Eli Lilly position peaked at $15.7M in Q1 2025.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.